Marco Marzioni Selected Research

Cholestasis

10/2022	TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation.
1/2022	Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis.
1/2021	Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis.
12/2020	Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
1/2018	MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.
8/2017	Primary Biliary Cholangitis: advances in management and treatment of the disease.
1/2017	Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice.
1/2016	The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
6/2014	Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice.
12/2011	Castration inhibits biliary proliferation induced by bile duct obstruction: novel role for the autocrine trophic effect of testosterone.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Marzioni Research Topics

Disease

27	Cholestasis 10/2022 - 05/2002
22	Fibrosis (Cirrhosis) 01/2022 - 02/2003
16	Neoplasms (Cancer) 01/2022 - 12/2005
16	Cholangiocarcinoma 01/2022 - 12/2005
14	Liver Diseases (Liver Disease) 01/2022 - 11/2002
11	Sclerosing Cholangitis 01/2022 - 04/2013
8	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 12/2008
6	Inflammation (Inflammations) 10/2022 - 10/2004
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 11/2002
4	Non-alcoholic Fatty Liver Disease 01/2017 - 09/2006
3	Disease Progression 01/2022 - 01/2017
3	Polycystic liver disease 01/2021 - 10/2015
3	Necrosis 01/2017 - 10/2004
3	Hyperplasia 10/2014 - 05/2007
2	Obesity 01/2022 - 09/2006
2	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 08/2017
2	Infections 01/2017 - 11/2007
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2017 - 10/2014
2	Dysbiosis 01/2017 - 05/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2015 - 10/2007
2	Insulin Resistance 01/2014 - 09/2006
1	Choledocholithiasis 01/2022
1	Hepatitis 01/2022
1	Overweight 01/2022
1	Cholelithiasis 12/2020
1	progressive familial intrahepatic 1 Cholestasis 12/2020
1	Intrahepatic Cholestasis of Pregnancy 12/2020
1	Hypertriglyceridemia 12/2020
1	Cholangitis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Pathologic Processes 01/2019
1	Hepatoblastoma 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

10	Bile Acids and Salts (Bile Acids)IBA 01/2018 - 05/2002
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
6	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022 - 10/2015
6	Messenger RNA (mRNA)IBA 01/2020 - 05/2006
6	Secretin FDA Link 01/2019 - 04/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 12/2005
5	Hormones (Hormone)IBA 02/2009 - 06/2006
3	Pharmaceutical PreparationsIBA 04/2021 - 11/2002
3	secretin receptorIBA 01/2019 - 01/2016
3	Bicarbonates (Hydrogen Carbonate)IBA 01/2019 - 11/2004
3	Ribavirin (Virazole)FDA LinkGeneric 10/2018 - 01/2014
3	Alkaline PhosphataseIBA 01/2018 - 01/2017
3	EnzymesIBA 01/2016 - 11/2008
3	CollagenIBA 10/2014 - 12/2005
3	NeuropeptidesIBA 08/2011 - 07/2008
3	Serotonin (5 Hydroxytryptamine)IBA 05/2010 - 01/2005
3	Biological ProductsIBA 07/2007 - 01/2007
2	BilirubinIBA 01/2020 - 08/2011
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2018
2	paritaprevirIBA 10/2018 - 01/2017
2	dasabuvirIBA 10/2018 - 01/2017
2	ombitasvirIBA 10/2018 - 01/2017
2	Ritonavir (Norvir)FDA Link 10/2018 - 01/2017
2	CytokinesIBA 01/2018 - 07/2003
2	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 02/2017 - 10/2014
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 09/2006
2	1-dodecylpyridoxal (PLD)IBA 01/2017 - 10/2015
2	Thioacetamide (Thioacetamid)IBA 02/2012 - 08/2008
2	Vascular Endothelial Growth Factor CIBA 08/2009 - 12/2005
2	Mitogen-Activated Protein Kinase 3IBA 08/2008 - 12/2005
2	Adrenergic Agents (Adrenergic Drugs)IBA 10/2007 - 05/2007
2	Neurotransmitter Agents (Neurotransmitter)IBA 05/2007 - 12/2005
2	Opioid Peptides (Opioid Peptide)IBA 04/2007 - 05/2006
2	Inositol (Myoinositol)IBA 04/2006 - 12/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2022
1	NanogelsIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2022
1	Therapeutic UsesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2021
1	SuspensionsIBA 04/2021
1	obeticholic acidIBA 04/2021
1	TransferasesIBA 01/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021
1	S-Adenosylmethionine (Ademetionine)IBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2020
1	Liver X ReceptorsIBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Oral ContraceptivesIBA 12/2020
1	Mannose ReceptorIBA 01/2020
1	IntegrinsIBA 01/2020
1	vedolizumabIBA 01/2020
1	CateninsIBA 01/2019

Therapy/Procedure

14	Therapeutics 01/2022 - 11/2002
10	Ligation 10/2022 - 10/2003
4	Liver Transplantation 01/2021 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2020 - 11/2008
2	Radiotherapy 05/2010 - 11/2008
2	Denervation 10/2007 - 05/2007
1	Aftercare (After-Treatment) 06/2021
1	Transplantation 01/2020